Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Waterboer

Showing results (111-120 of 431) with videos related to

Pageof 44
Sort By:
Oral Oncology|March 6, 2025
Post-treatment monitoring of surgically treated oropharyngeal squamous cell carcinoma patients using human papillomavirus cell-free DNAFabian Rosing, Michaela Plath, Tanja Proctor, et al.
Diagnostic and Prognostic Research|August 10, 2025
Calibrating multiplex serology for Helicobacter pyloriEmmanuelle A Dankwa, Martyn Plummer, Daniel Chapman, et al.
Helicobacter|November 21, 2019
Performance of multiplex serology in discriminating active vs past Helicobacter pylori infection in a primarily African American population in the southeastern United StatesJulia Butt, William J Blot, Martha J Shrubsole, et al.
Head & Neck|December 15, 2018
Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000Sarah Schimansky, Samantha Lang, Rhona Beynon, et al.
Bio-Protocol|March 3, 2021
<i>In situ</i>, Cell-free Protein Expression on Microarrays and Their Use for the Detection of Immune ResponsesKatrin Hufnagel, Dennis Reininger, Siu Wang Ng, et al.
Plos One|June 22, 2021
Seroprevalence of Chlamydia trachomatis, herpes simplex 2, Epstein-Barr virus, hepatitis C and associated factors among a cohort of men ages 18-70 years from three countriesShams Rahman, Deanna Wathington, Tim Waterboer, et al.
Cancer|March 15, 2021
Survival advantage in patients with human papillomavirus-driven oropharyngeal cancer and variation by demographic characteristics and serologic response: Findings from Head and Neck 5000Alex Whitmarsh, Miranda Pring, Steve J Thomas, et al.
Scientific Reports|June 12, 2026
Detection of recurrence of HPV-driven oropharyngeal cancer by HPV cell-free DNANoemi M Fricke, Vittoria Guarda, Daniela Höfler, et al.
International Journal of Cancer|November 22, 2017
Antibodies against human papillomaviruses as diagnostic and prognostic biomarker in patients with neck squamous cell carcinoma from unknown primary tumorLea Schroeder, Gunnar Wichmann, Maria Willner, et al.
Plos One|July 26, 2018
Cytomegalovirus (CMV) seroprevalence in the adult population of GermanyRaskit Lachmann, Anna Loenenbach, Tim Waterboer, et al.
Pageof 44

Showing results (111-120 of 431) with videos related to

Sort By:
Pageof 44
Oral Oncology|March 6, 2025
Post-treatment monitoring of surgically treated oropharyngeal squamous cell carcinoma patients using human papillomavirus cell-free DNAFabian Rosing, Michaela Plath, Tanja Proctor, et al.
Diagnostic and Prognostic Research|August 10, 2025
Calibrating multiplex serology for Helicobacter pyloriEmmanuelle A Dankwa, Martyn Plummer, Daniel Chapman, et al.
Helicobacter|November 21, 2019
Performance of multiplex serology in discriminating active vs past Helicobacter pylori infection in a primarily African American population in the southeastern United StatesJulia Butt, William J Blot, Martha J Shrubsole, et al.
Head & Neck|December 15, 2018
Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000Sarah Schimansky, Samantha Lang, Rhona Beynon, et al.
Bio-Protocol|March 3, 2021
<i>In situ</i>, Cell-free Protein Expression on Microarrays and Their Use for the Detection of Immune ResponsesKatrin Hufnagel, Dennis Reininger, Siu Wang Ng, et al.
Plos One|June 22, 2021
Seroprevalence of Chlamydia trachomatis, herpes simplex 2, Epstein-Barr virus, hepatitis C and associated factors among a cohort of men ages 18-70 years from three countriesShams Rahman, Deanna Wathington, Tim Waterboer, et al.
Cancer|March 15, 2021
Survival advantage in patients with human papillomavirus-driven oropharyngeal cancer and variation by demographic characteristics and serologic response: Findings from Head and Neck 5000Alex Whitmarsh, Miranda Pring, Steve J Thomas, et al.
Scientific Reports|June 12, 2026
Detection of recurrence of HPV-driven oropharyngeal cancer by HPV cell-free DNANoemi M Fricke, Vittoria Guarda, Daniela Höfler, et al.
International Journal of Cancer|November 22, 2017
Antibodies against human papillomaviruses as diagnostic and prognostic biomarker in patients with neck squamous cell carcinoma from unknown primary tumorLea Schroeder, Gunnar Wichmann, Maria Willner, et al.
Plos One|July 26, 2018
Cytomegalovirus (CMV) seroprevalence in the adult population of GermanyRaskit Lachmann, Anna Loenenbach, Tim Waterboer, et al.
Pageof 44